Your session is about to expire
← Back to Search
Wearable activity monitor for Cancer (DigiSTEPS Trial)
N/A
Waitlist Available
Led By Gillian Gresham, PhD
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights
Summary
The purpose of this study is to examine the relationships between objectively measured physical activity and provider-assessed and patient-reported functional outcomes in patients with advanced cancer. Findings from this study will help us better understand how change in daily physical activity, as measured using the wearable activity monitor, is related to change in a patient's functional status and clinical condition.
Eligible Conditions
- Cancer
- Tumors
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Absolute change in average step counts at 8 weeks from baseline
Absolute change in provider-assessed ECOG Performance Status at 8 weeks from baseline
Secondary outcome measures
Absolute change in patient-reported physical function at 8 weeks from baseline
Adherence to wearing the device for the specified study period
Change in frailty status from baseline to end-of-study visit (up to 8 weeks from baseline)
+3 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Wearable activity monitorExperimental Treatment1 Intervention
Continuous activity monitoring with Fitbit Charge HR from baseline to up to 1 year from end-of-study.
Find a Location
Who is running the clinical trial?
Cedars-Sinai Medical CenterLead Sponsor
509 Previous Clinical Trials
165,833 Total Patients Enrolled
Gillian Gresham, PhDPrincipal Investigator - Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
3 Previous Clinical Trials
98 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger